Sort
85,873 grants matching “alzheimers”
Test of Rapamycin in Aging Dogs (TRIAD)
$2,015,762Kate Elizabeth Creevy · Texas A&M Agrilife Research · R01 · FY2025 · AG
Dominantly Inherited Alzheimer Network: Clinical Core
$2,014,480John Morris · Washington University · U19 · FY2022 · AG
Exceptional Longevity Data Management and Coordinating Center
$2,012,724Susheel Varma · Sage Bionetworks · U24 · FY2024 · AG
Learning and decision-making in healthy aging and preclinical Alzheimer's Disease
$2,012,500Joseph W Kable · University Of Pennsylvania · RF1 · FY2017 · AG
Posttranslational Protein Modification in Alzheimer Pathology
$2,012,500Paul H. Axelsen · University Of Pennsylvania · RF1 · FY2018 · AG
Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease
$2,012,035Jessica Alber · University Of Rhode Island · R01 · FY2023 · AG
Role of O-GlcNAcylation in Regulating Neurodegeneration in Aging and Alzheimerâs Disease
$2,011,875Saul A Villeda · University Of California, San Francisco · RF1 · FY2018 · AG
Rush Alzheimer's Disease Core Center
$2,011,724David A Bennett · Rush University Medical Center · P30 · FY2009 · AG
NIA AD/ADRD Health Care Systems Research Collaboratory
$2,011,677Vincent Mor · Brown University · U54 · FY2022 · AG
Administrative Core
$2,011,452Teresa Gomez-Isla · Massachusetts General Hospital · P30 · FY2025 · AG
Dysregulated frontal-sensory network and cognitive control by Alzheimer's disease pathology
$2,011,345Hirofumi Morishita · Icahn School Of Medicine At Mount Sinai · RF1 · FY2024 · AG
Emergency General Surgery Delirium Recovery Model: A Collaborative Care Intervention
$2,011,326Ben L Zarzaur · University Of Wisconsin-Madison · R01 · FY2025 · AG
Long-term impact of random assignment to intensive lifestyle intervention on Alzheimers disease and related dementias: The Action for Health in Diabetes ADRD Study (Look AHEAD-MIND)
$2,011,249Mark Andrew Espeland · Wake Forest University Health Sciences · R01 · FY2019 · AG
Gene Therapy for Alzheimer's Disease
$2,010,177Salk Institute For Biological Studies · P01 · FY2005 · AG
Immunotherapy Targeting Tau Aggregate Polymorphs
$2,009,600Rakez Kayed · University Of Texas Med Br Galveston · RF1 · FY2022 · AG
Pathophysiological Signaling in Neurodegenerative Disorders
$2,009,438Jonathan David Geiger · University Of North Dakota · P20 · FY2007 · RR
Exceptional Longevity Data Management and Coordinating Center
$2,009,268Susheel Varma · Sage Bionetworks · U24 · FY2025 · AG
Main Administrative Core
$2,008,967Anne M Murray · Hennepin Healthcare Research Institute · U19 · FY2021 · AG
Retromer deficiency and Alzheimer's disease pathology
$2,008,958Wen-Cheng Xiong · Case Western Reserve University · RF1 · FY2019 · AG
Clinical and Informatics Research on Large Clinical Databases
$2,008,861Clement McDonald · National Library Of Medicine · ZIA · FY2023 · LM
A Human iPSC-Based Chimeric Mouse Model of Alzheimers Disease in Down Syndrome
$2,008,397Peng Jiang · Rutgers, The State Univ Of N.J. · R01 · FY2021 · AG
Alzheimer's Disease and Related Disorders Treatment and Outcomes in America: Changing Policies and Systems
$2,008,227Vincent Mor · Brown University · P01 · FY2021 · AG
Technical Core
$2,007,898Michael Robert Kellen · Northwestern University At Chicago · U2C · FY2024 · AG
1Florida Alzheimer's Disease Research Center Clinical Core
$2,007,554Ranjan Duara · University Of Florida · P30 · FY2022 · AG
Inflammatory contributions of astrocytic RelA in comorbid VCID/AD
$2,006,540Josh Morganti · University Of Kentucky · RF1 · FY2020 · NS